| Document And Entity Information | 3 Months Ended | |
| Jun. 30, 2014 | Aug. 14, 2014 | |
| Document And Entity Information [Abstract] | ' | ' |
| Entity Registrant Name | 'KollagenX Corp. | ' |
| Entity Central Index Key | '0001402486 | ' |
| Trading Symbol | 'kgnx | ' |
| Current Fiscal Year End Date | '--03-31 | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' |
| Entity Common Stock, Shares Outstanding | ' | 64,000,000 |
| Document Type | '10-Q | ' |
| Document Period End Date | 30-Jun-14 | ' |
| Amendment Flag | 'true | ' |
| Amendment Description | 'To add the xbrl to the filing | ' |
| Document Fiscal Year Focus | '2014 | ' |
| Document Fiscal Period Focus | 'Q1 | ' |
| Condensed Balance Sheets (USD $) | Jun. 30, 2014 | Mar. 31, 2014 |
| Current Assets | ' | ' |
| Cash | $4,161 | $22 |
| Prepaid expenses | 3,879 | 1,260 |
| Total Current Assets | 8,040 | 1,282 |
| Total Assets | 8,040 | 1,282 |
| Current Liabilities | ' | ' |
| Accounts payable | 6,175 | 2,425 |
| Accrued interest | 6,738 | ' |
| Notes payable | 136,000 | ' |
| Total Current Liabilities | 148,914 | 127,876 |
| Total Liabilities | 148,914 | 127,876 |
| Stockholders' Deficit | ' | ' |
| Common stock, ($0.001 par value, 750,000,000 shares authorized; 64,000,000 shares issued and outstanding as at June 30, 2014 and March 31, 2014 | 54,000 | 54,000 |
| Additional paid-in capital | 3,000 | 3,000 |
| Deficit accumulated during exploration stage | -197,873 | -183,594 |
| Total Stockholders' Deficit | -140,873 | -126,594 |
| TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT | $8,040 | $1,282 |
| Condensed Balance Sheets (Parenthetical) (USD $) | Jun. 30, 2014 | Mar. 31, 2014 |
| Statement of Financial Position [Abstract] | ' | ' |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 |
| Common stock, shares authorized | 750,000,000 | 750,000,000 |
| Common stock, shares issued | 54,000,000 | 54,000,000 |
| Common stock, shares, outstanding | 54,000,000 | 54,000,000 |
| Condensed Statements of Operations (Unaudited) (USD $) | 3 Months Ended | 88 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | |
| Revenues | ' | ' | ' |
| Revenues | ' | ' | ' |
| Total Revenues | ' | ' | ' |
| Expenses | ' | ' | ' |
| Professional fees | 4,000 | 4,942 | 79,125 |
| General & administrative expenses | 8,992 | 8,599 | 112,010 |
| Net Operating Loss | 12,992 | 13,541 | 191,135 |
| Other Expenses | ' | ' | ' |
| Interest expense | 1,288 | 840 | 6,738 |
| Net Loss | ($14,280) | ($14,381) | ($197,873) |
| Basic loss per share (in dollars per share) | $0 | $0 | ' |
| Weighted average number of common shares outstanding (in shares) | 54,000,000 | 54,000,000 | ' |
| Condensed Statements of Cash Flows (Unaudited) (USD $) | 3 Months Ended | 88 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' | ' |
| Net loss | ($14,280) | ($14,381) | ($197,873) |
| Changes in operating assets and liabilities: | ' | ' | ' |
| Prepaid expenses | -2,619 | 1,947 | -3,879 |
| Accounts payable and accrued liabilities | 5,038 | 1,314 | 12,914 |
| Net cash used in operating activities | -11,861 | -11,120 | -188,839 |
| CASH FLOWS FROM INVESTING ACTIVITIES | ' | ' | ' |
| Net cash provided by (used in) investing activities | ' | ' | ' |
| CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' | ' |
| Note payable | 16,000 | 20,000 | 136,000 |
| Issuance of common stock | ' | ' | 57,000 |
| Net cash provided by financing activities | 16,000 | 20,000 | 193,000 |
| Net increase (decrease) in cash | 4,139 | 8,880 | 4,161 |
| Cash at beginning of period | 22 | 7,156 | ' |
| Cash at end of period | 4,161 | 16,036 | 4,161 |
| Cash paid during period for : | ' | ' | ' |
| Interest | ' | ' | ' |
| Income Taxes | ' | ' | ' |
| Basis of Presentation | 3 Months Ended |
| Jun. 30, 2014 | |
| Basis Of Presentation [Abstract] | ' |
| Basis of Presentation | ' |
| Note 1. Basis of Presentation | |
| The accompanying unaudited interim financial statements of KollagenX Corp. (f/k/a Integrated Electric Systems Inc.), have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in KollagenX’s Form 10-K filed with SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2014 as reported in the Form 10-K have been omitted. It is management's opinion that all adjustments necessary for a fair statement of the results of the interim periods have been made, and all adjustments are of a normal recurring nature. |
| Going Concern | 3 Months Ended |
| Jun. 30, 2014 | |
| Going Concern [Abstract] | ' |
| Going Concern | ' |
| Note 2. Going Concern | |
| The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has no sales and has incurred a net loss of $197,873 since inception. The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from any business the Company engages in. The financial statements do not include any adjustments relating to the recoverability and classifications of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. These factors raise substantial doubt regarding KollagenX’s ability to continue as a going concern. |
| Notes Payable | 3 Months Ended | ||||
| Jun. 30, 2014 | |||||
| Debt Disclosure [Abstract] | ' | ||||
| Notes Payable | ' | ||||
| Note 3. Notes Payable | |||||
| Notes payable as of June 30, 2014 are: | |||||
| Unsecured promissory note payable, dated August 13, 2012 | $ | 30,000 | |||
| bearing interest at 4% per annum, due August 13, 2014 | |||||
| Unsecured promissory note payable, dated December 18, 2012 | 50,000 | ||||
| bearing interest at 4% per annum, due December 18, 2014. | |||||
| Unsecured promissory note payable, dated June 13, 2013 | 20,000 | ||||
| bearing interest at 4% per annum, due June 13, 2015. | |||||
| Unsecured promissory note payable, dated October 7, 2013 | 10,000 | ||||
| bearing interest at 4% per annum, due October 7, 2014. | |||||
| Unsecured promissory note payable, dated December 18, 2013 | 5,000 | ||||
| bearing interest at 4% per annum, due December 18, 2014. | |||||
| Unsecured promissory note payable, dated February 19, 2014 | 5,000 | ||||
| bearing interest at 4% per annum, due February 19, 2015. | |||||
| Unsecured promissory note payable, dated April 16, 2014 | 10,000 | ||||
| bearing interest at 4% per annum, due April 16, 2015. | |||||
| Unsecured promissory note payable, dated June 24, 2014 | 6,000 | ||||
| bearing interest at 4% per annum, due June 24, 2015. | |||||
| $ | 136,000 | ||||
| Interest expense incurred under debt obligations amounted to $1,288 and $840 for the three months ended June 30, 2014 and 2013, respectively. Accrued interest was $6,738 and $5,450 as of June 30, 2014 and March 31, 2014, respectively. | |||||
| Subsequent Event | 3 Months Ended |
| Jun. 30, 2014 | |
| Subsequent Events [Abstract] | ' |
| Subsequent Event | ' |
| Note 3. Subsequent Event | |
| On August 4, 2014, the Company acquired KollagenX Corp. in a stock purchase agreement where as a result of the consummation of the actions contemplated by the Stock Purchase Agreement, KollagenX Corp became the Company’s wholly owned subsidiary. Upon consummation, the Company merged with its wholly owned subsidiary and changed its name from Integrated Electric Systems, Inc. to KollagenX Corp. with a new trading symbol of KGNX. The Company issued 10,000,000 shares of common stock to acquire 100% of KollagenX Corp. |
| Notes Payable (Tables) | 3 Months Ended | ||||
| Jun. 30, 2014 | |||||
| Debt Disclosure [Abstract] | ' | ||||
| Schedule of notes payable | ' | ||||
| Notes payable as of June 30, 2014 are: | |||||
| Unsecured promissory note payable, dated August 13, 2012 | $ | 30,000 | |||
| bearing interest at 4% per annum, due August 13, 2014 | |||||
| Unsecured promissory note payable, dated December 18, 2012 | 50,000 | ||||
| bearing interest at 4% per annum, due December 18, 2014. | |||||
| Unsecured promissory note payable, dated June 13, 2013 | 20,000 | ||||
| bearing interest at 4% per annum, due June 13, 2015. | |||||
| Unsecured promissory note payable, dated October 7, 2013 | 10,000 | ||||
| bearing interest at 4% per annum, due October 7, 2014. | |||||
| Unsecured promissory note payable, dated December 18, 2013 | 5,000 | ||||
| bearing interest at 4% per annum, due December 18, 2014. | |||||
| Unsecured promissory note payable, dated February 19, 2014 | 5,000 | ||||
| bearing interest at 4% per annum, due February 19, 2015. | |||||
| Unsecured promissory note payable, dated April 16, 2014 | 10,000 | ||||
| bearing interest at 4% per annum, due April 16, 2015. | |||||
| Unsecured promissory note payable, dated June 24, 2014 | 6,000 | ||||
| bearing interest at 4% per annum, due June 24, 2015. | |||||
| $ | 136,000 | ||||
| Going Concern (Details Narrative) (USD $) | 3 Months Ended | 88 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | |
| Going Concern [Abstract] | ' | ' | ' |
| Net loss | ($14,280) | ($14,381) | ($197,873) |
| Notes Payable (Details) (USD $) | Jun. 30, 2014 |
| Debt Instrument [Line Items] | ' |
| Notes payable | $136,000 |
| Unsecured Promissory Note Payable Dated 7 October 2013 [Member] | Notes Payable [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Notes payable | 10,000 |
| Unsecured Promissory Note Payable Dated 13 August 2012 [Member] | Notes Payable [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Notes payable | 30,000 |
| Unsecured Promissory Note Payable Dated 18 December 2012 [Member] | Notes Payable [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Notes payable | 50,000 |
| Unsecured Promissory Note Payable Dated 13 June 2013 [Member] | Notes Payable [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Notes payable | 20,000 |
| Unsecured Promissory Note Payable Dated 18 December 2013 [Member] | Notes Payable [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Notes payable | $5,000 |
| Notes Payable II (Details) (Notes Payable [Member]) | 3 Months Ended |
| Jun. 30, 2014 | |
| Unsecured Promissory Note Payable Dated 18 December 2012 [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Interest rate on unsecured promissory note payable | 4.00% |
| Notes payable due date | 18-Dec-14 |
| Unsecured Promissory Note Payable Dated 13 June 2013 [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Interest rate on unsecured promissory note payable | 4.00% |
| Notes payable due date | 13-Jun-14 |
| Unsecured Promissory Note Payable Dated 7 October 2013 [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Interest rate on unsecured promissory note payable | 4.00% |
| Notes payable due date | 7-Oct-14 |
| Unsecured Promissory Note Payable Dated 18 December 2013 [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Interest rate on unsecured promissory note payable | 4.00% |
| Notes payable due date | 18-Dec-14 |
| Unsecured Promissory Note Payable Dated 13 August 2012 [Member] | ' |
| Debt Instrument [Line Items] | ' |
| Interest rate on unsecured promissory note payable | 4.00% |
| Notes payable due date | 13-Aug-14 |
| Notes Payable (Detail Narrative) (USD $) | 3 Months Ended | 88 Months Ended | |
| Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | |
| Debt Disclosure [Abstract] | ' | ' | ' |
| Interest expense | $1,288 | $840 | $6,738 |
| Accrued interest | $6,738 | ' | $6,738 |
